PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27832654-2	2017	METHODS: An 18FDG-PET performed following the first cycle of chemotherapy (PET-1) was compared with a pretreatment 18FDG-PET (PET-0) and a computed tomography (CT) scan after the third cycle (CT-3).	Fluorodeoxyglucose F18	12-17	FEV transcription factor, ETS family member	Homo sapiens	75-80	
20017002-8	2010	Malignant lesions showed an increase in FDG uptake between PET-1 and PET-2, with a Delta% SUV(max) of 10+/-7 (p<0.04).	Fluorodeoxyglucose F18	40-43	FEV transcription factor, ETS family member	Homo sapiens	59-64	
17129635-7	2007	The difference between initial FDG uptake (PET 1) and uptake after induction chemotherapy (PET 2) was found to be highly predictive for long-term survival patients which had a greater than 60% decreases in their SUV change had a significantly longer survival than those below this threshold (5-year-survival 60% versus 15%, p=0.0007).	Fluorodeoxyglucose F18	31-34	FEV transcription factor, ETS family member	Homo sapiens	43-48	
17129635-9	2007	Furthermore, the difference between initial FDG uptake (PET 1) and uptake after completion of the whole NARCT (PET 3) was predictive for survival when 75% was applied as cut-off (p=0.02).	Fluorodeoxyglucose F18	44-47	FEV transcription factor, ETS family member	Homo sapiens	56-61	
16216761-6	2005	Changes over time in the mean FDG uptake were statistically significant between PET1 and PET2 in the apical inferior, apical-posterior, apical-anterior, apical antero-septal, apical infero-septal, mid-inferior and mid-infero-septal segments.	Fluorodeoxyglucose F18	30-33	FEV transcription factor, ETS family member	Homo sapiens	80-84	
29616304-10	2018	The change of FDG uptake between PET1 and PET2 (DeltaSUVmax) was highly associated with pCR (P = 0.0001) but the absolute value of baseline SUVmax was not (P = 0.11).	Fluorodeoxyglucose F18	14-17	FEV transcription factor, ETS family member	Homo sapiens	33-37	
11249046-8	2001	Out of 28 negative 18FDG-PET 1 relapse developed 3 years later.	Fluorodeoxyglucose F18	19-24	FEV transcription factor, ETS family member	Homo sapiens	25-30